Nafpenzal DC Intramammary Suspension

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Procaine benzylpenicillin; Dihydrostreptomycin sulphate ; Nafcillin sodium

Available from:

Intervet Ireland Limited

ATC code:

QJ51RC23

INN (International Name):

Procaine benzylpenicillin; Dihydrostreptomycin sulphate ; Nafcillin sodium

Dosage:

300, 100, 100 mg/syringe

Pharmaceutical form:

Intramammary suspension

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Cattle

Therapeutic area:

procaine benzylpenicillin, combinations with other antibacterials

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

1987-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nafpenzal DC Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary suspension.
White, to off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dry cows
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
To treat existing mastitis at drying off and to provide protection
against further infections during the dry period.
Susceptible organisms include:_ Staphylococcus aureus, Streptococcus
agalactiae, Streptococcus dysgalactiae,_
_Streptococcus uberis_ and_ Escherichia coli_
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to penicillin, nafcillin or
dihydro-streptomycin, or to any of the excipients.
Do not use in lactating animals.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each 3 g syringe contains:
ACTIVE SUBSTANCES:
Procaine benzylpenicillin
300 mg
Dihydrostreptomycin(as the sulfate)
100 mg
Nafcillin (as the sodium salt)
100 mg
For the full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_1_
_0_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_1_
_1_
_8_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Penicillin and cephalosporins may cause hypersensitivity (allergy)
following